Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Bitcoin

S&P 500 Snub Deals Major Blow to MicroStrategy’s Bitcoin Ambitions

Robert Sasse by Robert Sasse
September 6, 2025
in Bitcoin, Blockchain, Crypto Stocks, S&P 500
0
Strategy Stock
0
SHARES
185
VIEWS
Share on FacebookShare on Twitter

In a move that stunned market participants, the committee overseeing the S&P Dow Jones Indices rejected MicroStrategy’s inclusion in the benchmark index this past Friday. The business intelligence firm, which recently rebranded as Strategy Inc., was passed over despite meeting all formal technical requirements for admission, including sufficient market capitalization and four consecutive profitable quarters. Instead, the coveted spots were awarded to Robinhood, AppLovin, and Emcor Group.

This exclusion represents a significant setback for the company. Inclusion would have compelled index-tracking funds to purchase its stock, and market experts had projected potential inflows of approximately $16 billion. The disappointment triggered an immediate sell-off, sending the company’s shares tumbling in after-hours trading.

A High-Stakes Strategy Faces Scrutiny

The decision is widely interpreted as a pointed critique of MicroStrategy’s singular focus. While the traditional financial market shows it a cold shoulder, the company continues to aggressively pursue its Bitcoin acquisition strategy. It now holds a colossal 214,400 Bitcoin, a stash valued at over $70 billion and the largest of any publicly traded corporation worldwide.

Should investors sell immediately? Or is it worth buying Strategy?

However, this massive expansion has come at a considerable cost. To fund its relentless Bitcoin purchases, MicroStrategy has systematically diluted existing shareholders through substantial secondary stock offerings. The company recently broke its own promise not to sell shares below a specific valuation multiple, underscoring the immense pressure to continue funding its crypto acquisitions.

Growing Disconnect Between Assets and Valuation

A particularly troubling trend for investors is the growing divergence between the company’s Bitcoin holdings and its stock performance. Although the Bitcoin treasury has more than doubled since the stock’s peak in late 2024, the share price has failed to keep pace. Consequently, each share now represents a significantly larger underlying Bitcoin value, a fact the market has so far refused to reward appropriately.

The S&P committee’s verdict appears to signal deep institutional skepticism regarding the sustainability of MicroStrategy’s high-risk, crypto-centric business model. The subsequent downward trend in the stock price following the news highlights a critical moment of reassessment for the pioneering Bitcoin corporate holder.

Ad

Strategy Stock: Buy or Sell?! New Strategy Analysis from February 7 delivers the answer:

The latest Strategy figures speak for themselves: Urgent action needed for Strategy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Strategy: Buy or sell? Read more here...

Tags: Strategy
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Diginex Stock
Blockchain

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
S&P 500 Stock
Market Commentary

US Benchmark Index Breaches Key Threshold Amid Tech and Jobs Concerns

February 6, 2026
Bitcoin Stock
Bitcoin

Bitcoin Plummets Amidst Widespread Market Liquidation

February 6, 2026
Next Post
Eli Lilly Stock

Lilly's Oncology Breakthrough: Cancer Drug Designation Signals Pipeline Strength

OceanFirst Stock

OceanFirst's Strategic Moves Amid Mixed Financial Performance

US Physical Therapy Stock

Mixed Signals Emerge as US Physical Therapy Posts Record Results Amid Insider Sales

Recommended

CRWD stock news

Tower Research Capital LLC TRC Demonstrates Unwavering Confidence in CrowdStrike Holdings as Cybersecurity Leader

2 years ago
Efficiently Reporting an Absence on WalmartOne: A Step-by-Step Guide for Employees

Beacon Announces Interim Chief Financial Officer

2 years ago

Alaska Airlines Boeing 737 Investigation Missing Bolts and Safety Measures

2 years ago

Impressive Financial Performance for Kiniksa Pharmaceuticals

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Trending

Universal Insurance Stock
Analysis

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

by Rodolfo Hanigan
February 7, 2026
0

Universal Insurance Holdings has reaffirmed its commitment to shareholder returns, declaring its regular quarterly dividend despite a...

Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts
  • Camping World’s New Leadership Faces First Major Test

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com